These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4385975)

  • 41. In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.
    Goldstein E; Eagle MC; LaCasse ML
    Appl Microbiol; 1971 Sep; 22(3):329-33. PubMed ID: 4330314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 44. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 45. [Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].
    Golychevskaja VI
    G Ital Chemioter; 1972; 19(2):20-2. PubMed ID: 4199029
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 47. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. VII. September 1965 to September 1969.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1970 Sep; 102(3):347-55. PubMed ID: 4989604
    [No Abstract]   [Full Text] [Related]  

  • 48. Primary drug-resistant Mycobacterium tuberculosis isolated in Massachusetts in 1972.
    Stottmeier KD; Burkes J
    J Infect Dis; 1974 Sep; 130(3):293-294. PubMed ID: 4213310
    [No Abstract]   [Full Text] [Related]  

  • 49. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 50. Studies on the mode of action of isoniazid on mycobacteria.
    Bekierkunst A; Bricker A
    Arch Biochem Biophys; 1967 Nov; 122(2):385-92. PubMed ID: 4294445
    [No Abstract]   [Full Text] [Related]  

  • 51. Antibiotics, antiseptics and tubercle bacilli.
    McDonald PJ; Murray CJ; McDonald HM
    Med J Aust; 1974 Jul; 2(2):41-5. PubMed ID: 4212945
    [No Abstract]   [Full Text] [Related]  

  • 52. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. II. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with SM- and INH-resistant Schacht strain.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):45-54. PubMed ID: 4295381
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on the endogenous metabolism of mycobacteria. 3. On the influence of isonicotinic acid hydrazide on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H
    Z Naturforsch B; 1968 Jul; 23(7):982-9. PubMed ID: 4387665
    [No Abstract]   [Full Text] [Related]  

  • 54. [Advances and principles in tuberculostatic therapy].
    Bethge H
    Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
    [No Abstract]   [Full Text] [Related]  

  • 55. [Endocavernous treatment of caverns with atypical Mycobacteria].
    Neef W
    Z Erkr Atmungsorgane Folia Bronchol; 1970 Jun; 131(5):385-9. PubMed ID: 5210837
    [No Abstract]   [Full Text] [Related]  

  • 56. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparison of the sensitivity to ethionamide, thiacetazone and isoxyl of tubercle bacilli from previously untreated patients in Tokyo.
    Fukuhara Y; Kobayashi H; Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):57-61. PubMed ID: 4097677
    [No Abstract]   [Full Text] [Related]  

  • 58. [Drug resistance of Mycobacterium tuberculosis].
    Malaguzzi Valeri F; Rossi F
    G Pneumol; 1970 Apr; 14(2):121-5. PubMed ID: 5005066
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
    Lai CC; Tan CK; Huang YT; Liao CH; Hsueh PR
    J Antimicrob Chemother; 2011 Oct; 66(10):2437-8. PubMed ID: 21798881
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experimental chemotherapy of tuberculosis].
    Krebs A
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(5):417-48. PubMed ID: 4899157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.